You just read:

Citius Pharmaceuticals, Inc. Provides Phase 3 Update On Mino-Lok™ Clinical Trial Following FDA Meeting

News provided by

Citius Pharmaceuticals, Inc.

Sep 05, 2017, 07:00 ET